Skip to main content
. 2023 May 12;10(5):585. doi: 10.3390/bioengineering10050585

Table 1.

Demographic and clinical characteristics of participants.

Experimental Group (n = 17) Control Group (n = 21) p-Value
Median IQR Median IQR
Age (yr) 68.0 (56.5–74.5) 70.0 (63.5–74.5) 0.527
Sex (n,%) 0.444
Male 11 (64.71%) 11 (52.38%)
Female 6 (35.29%) 10 (47.62%)
Height (cm) 158.00 (155.50–168.25) 160.00 (158.10–165.50) 0.499
Weight (kg) 69.40 (57.65–70.95) 72.00 (60.60–77.30) 0.122
BMI 24.60 (21.90–27.35) 26.70 (23.56–29.48) 0.082
NIHSS score 6 (3–10) 7 (4.5–11.5) 0.594
HbA1C (%) 6.30 (5.60–7.15) 6.60 (6.20–7.55) 0.181
LDL (mg/dL) 105.00 (78.00–135.00) 121.00 (100.50–179.00) 0.072
Homocysteine (μmol/L) 11.05 (7.99–12.52) 11.00 (9.50–16.00) 0.310
Stroke type (n,%) 1.000
Hemorrhagic 5 (29.41%) 6 (28.57%)
Ischemic 12 (70.59%) 15 (71.43%)
Stroke site (n,%) 0.407
Left 6 (35.29%) 11 (52.38%)
Right 10 (58.82%) 10 (47.62%)
Bilateral 1 (5.88%) 0 (0%)
Pre-rehabilitation data
Ext. 60 (N⋅m) 10.00 (4.35–20.20) 10.00 (8.00–13.50) 0.755
Flex. 60 (N⋅m) 9.10 (6.50–10.90) 11.00 (8.50–14.50) 0.095
Ext. 120 (N⋅m) 9.90 (3.95–14.25) 12.00 (9.00–14.50) 0.176
Flex. 120 (N⋅m) 11.60 (8.00–15.00) 15.00 (10.50–17.50) 0.066
6MWT (m) 10.00 (6.00–37.50) 10.00 (8.50–12.00) 0.867
TUG (s) 61.33 (50.00–115.86) 57.07 (41.16–70.29) 0.107
SF-12 108.50 (71.63–114.78) 106.90 (100.61–112.24) 0.685

IQR = interquartile range; BMI = body mass index; LDL = low-density lipoprotein; Ext. 60 = extension torque at 60 degrees per second; Flex. 60 = flexion torque at 60 degrees per second; Ext. 120 = extension torque at 120 degrees per second; Flex. 120 = flexion torque at 120 degrees per second; 6 MWT = 6 min walk test; TUG = Timed Up-and-Go test; SF-12 = 12-Item Short Form Survey.